Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visnadine, Prenylflavonoids, and Bovine Colostrum Cream for Vulvovaginal Atrophy
NCT03281655Phase 2Completed
- Sponsor
- University of Messina
- Start
- Dec 2016
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
01
Overview
A Phase 2 trial of visnadine, bovine colostrum in Vulvovaginal atrophy (VVA), sponsored by University of Messina. Started Dec 2016; status: completed.
02
Drugs
visnadinebovine colostrum
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT03281655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03281655.